LPAR3, lysophosphatidic acid receptor 3, 23566

N. diseases: 194; N. variants: 3
Disease: Metabolic Diseases ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases 		0.040 Biomarker group BEFREE The current state of GPCR-based drug discovery to treat metabolic disease. 29394497 2018
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases 		0.040 Biomarker group BEFREE TGR5 is a member of G protein-coupled receptor (GPCR) superfamily, a promising molecular target for metabolic diseases. 29655980 2018
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases 		0.040 Biomarker group BEFREE Pathway analysis then demonstrated that IL23-mediated signaling events, interferon gamma signaling, natural killer (NK)-κB signaling pathway, chemokine receptors that bind chemokines, GPCR ligand binding, and metabolic disorders of biological oxidation enzyme pathways play important roles in NMO. 26941100 2017
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases 		0.040 Biomarker group BEFREE Since the discovery of the lysophospholipid-sensitive receptor GPR55, hopes have been raised that targeting this G protein-coupled receptor (GPCR) may represent a novel approach for the treatment of metabolic disorders. 27215467 2016